MStranslate logo
Log In
Lost your password?
Lost Password
Back to login
Search
  • HOME
  • Research
    • Basic Sciences
      • B Cells
    • Conferences
      • AAN
      • ACTRIMS
      • ECTRIMS
      • MS Virtual
    • COVID-19
    • Epstein-Barr virus
    • Genetics
    • Gut Microbiome
    • Hormones
    • Lifestyle
      • Diet
      • Exercise
      • Jelinek Group
      • Vitamin D
    • Medicinal Cannabis
    • Mental Health
    • Progressive MS
    • Remyelination
    • Stem Cells
    • Symptoms
      • Cognition
      • Fatigue
      • Quality of Life
      • Rehabilitation
  • Treatments
    • Alemtuzumab
    • Daclizumab
    • Dimethyl fumarate
    • Fingolimod
    • Interferon-Beta
    • Laquinimod
    • Natalizumab
    • Ocrelizumab
    • Clinical Trials & Studies
      • MIS416
  • Lifestyle
  • Collaborations
    • Dr Sally Shaw
    • Dr Travis Stiles
    • Employment & MS
    • Kriesel Lab
    • MBC@RMH
      • MSBase@MBC
      • PrevANZ
      • Neuroimaging
      • Basic Sciences
      • Ocular Motor
      • Movement Disorders & Rehabilitation
    • MitoQ
    • Multiple Sclerosis Limited
  • Connect
    • Live Research Q&A
  • About MStranslate
    • THE TEAM
    • THE APPROACH
    • VALUES & STANDARDS
  • Contact Us
Breaking
  • FDA Decision On Tolebrutinib
  • Multiple Sclerosis Research In 2026
  • Revisiting ECTRIMS Congress 2025
  • UPDATED: The ECTRIMS Podcast - Episode Library
  • Patient Community Day at ECTRIMS 2025
  • Multiple Sclerosis in 2025 – Key Developments to Date
  • HOME
  • Research
    • Basic Sciences
      • B Cells
    • Conferences
      • AAN
      • ACTRIMS
      • ECTRIMS
      • MS Virtual
    • COVID-19
    • Epstein-Barr virus
    • Genetics
    • Gut Microbiome
    • Hormones
    • Lifestyle
      • Diet
      • Exercise
      • Jelinek Group
      • Vitamin D
    • Medicinal Cannabis
    • Mental Health
    • Progressive MS
    • Remyelination
    • Stem Cells
    • Symptoms
      • Cognition
      • Fatigue
      • Quality of Life
      • Rehabilitation
  • Treatments
    • Alemtuzumab
    • Daclizumab
    • Dimethyl fumarate
    • Fingolimod
    • Interferon-Beta
    • Laquinimod
    • Natalizumab
    • Ocrelizumab
    • Clinical Trials & Studies
      • MIS416
  • Lifestyle
  • Collaborations
    • Dr Sally Shaw
    • Dr Travis Stiles
    • Employment & MS
    • Kriesel Lab
    • MBC@RMH
      • MSBase@MBC
      • PrevANZ
      • Neuroimaging
      • Basic Sciences
      • Ocular Motor
      • Movement Disorders & Rehabilitation
    • MitoQ
    • Multiple Sclerosis Limited
  • Connect
    • Live Research Q&A
  • About MStranslate
    • THE TEAM
    • THE APPROACH
    • VALUES & STANDARDS
  • Contact Us

Research

Home
Research
Human Endogenous Retroviruses

Human Endogenous Retroviruses & MS

MStranslate
August 4, 2015
Collaboration, Research
Dr John Kriesel, head of the Kriesel Lab at the University of Utah, provides an overall introduction to his team.  In particular, he discusses their investigations into the link between human endogenous...
Multiple Sclerosis

Diet and Multiple Sclerosis

MStranslate
July 27, 2015
Diet, Lifestyle, Research
We all know that a healthy diet is important for our well-being, but does it differ for people with multiple sclerosis? As something that can be "controlled", diet is a constant topic of discussion in the MS...
Secretogranin-1

Secretogranin-1: A Potential New Biomarker for MS

MStranslate
July 16, 2015
Research
Recent studies have shown that early administration of therapies lead to better long-term outcomes for people with multiple sclerosis (MS). Therefore, it is of interest to identify methods that enable an early...
Jonathan Kipnis

Lymphatic System in the Brain: Prof Jonathan Kipnis

MStranslate
July 7, 2015
Research
In early June, media outlets across the world featured groundbreaking research undertaken by the Kipnis Lab at the University of Virginia. Published in Nature, this study showed the presence of a lymphatic...

Compound Reduces Neurodegeneration in Mouse Model of MS

MStranslate
June 2, 2015
Research
Researchers from Virginia Commonwealth University and the University of Illinois at Chicago have identified a compound that is able to reduce neurodegeneration in a mouse model of multiple sclerosis. The...

Vitamin D – All About the Timing?

MStranslate
May 19, 2015
Lifestyle, Research, Vitamin D
There has been a long-held belief that low-levels of Vitamin D may increase the risk of developing multiple sclerosis. This has been supported by the worldwide distribution of MS, where lower rates are...

Vitamin B7 – Potential New Therapy for Progressive MS

MStranslate
May 13, 2015
Research, Treatments
Progressive MS is (finally) starting to be a major focus of MS research - both in trying to understand what triggers the shift from the relapsing-remitting form and in the development of effective treatments...

Nanoparticles Used to Deliver Myelin Repair Molecule

MStranslate
May 7, 2015
Research, Treatments
In recent years, a large focus of MS research around the world has been promoting remyelination - that is, the process of repairing damaged nerves. In a recent study published in Biomaterials Science, a team...

Prolactin: A Novel Therapy for Multiple Sclerosis?

MStranslate
April 23, 2015
Research
By Brett Drummond Prolactin, the hormone responsible for milk production in women, has been previously shown to have the ability to remyelinate damaged nerves.  Therefore, it's potential for use as a...

Psychological Adjustment to Multiple Sclerosis

MStranslate
March 27, 2015
Recruitment, Research
Today, we're featuring a video filmed with clinical psychology student Lis Morley from The University of Melbourne. In it, Lis introduces her research investigating a possible connection between an...
  1. 17
  2. 18
  3. 19
  4. 20
  5. 21
  6. 22
  7. 23

Recent Posts

  • FDA Decision On Tolebrutinib
  • Multiple Sclerosis Research In 2026
  • Revisiting ECTRIMS Congress 2025
  • UPDATED: The ECTRIMS Podcast – Episode Library
  • Patient Community Day at ECTRIMS 2025

Recent Comments

  • FDA Decision On Tolebrutinib - MStranslate on Multiple Sclerosis in 2025 – Key Developments to Date
  • Treatment With Gut Bacteria Shows Benefits In New Study on Gut Bacteria in People Living with RRMS
  • Community Q&A: COVID-19 Vaccines & Multiple Sclerosis on Community Q&A: The Blood-Brain Barrier
  • Community Q&A: Why Don't We Have A Multiple Sclerosis Cure? on Community Q&A: COVID-19 Vaccines & MS
  • Tim Little on FAKE NEWS ALERT: COVID Vaccines & MS

Calendar

March 2026
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
« Jan    

Archives

Categories

Posts

  • FDA Decision On Tolebrutinib
  • Multiple Sclerosis Research In 2026
  • Revisiting ECTRIMS Congress 2025
  • UPDATED: The ECTRIMS Podcast – Episode Library
  • Patient Community Day at ECTRIMS 2025

Google+

Get social

Copyright 2014-2018 MStranslate. All Rights Reserved. Contact Us
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.